Global Serological Pipettes Market Strategic Research Report
By Type: Polystyrene, Glass
By Application: cademic Research Laboratories, Pharmaceutical R&D Centers, Clinical Testing Laboratories, Blood Banking Facilities, Biotechnology Production Facilities
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Corning, Thermo Fisher Scientific, Mettler Toledo, Greiner Bio-One, Eppendorf, Sarstedt, DWK Life Sciences, CELLTREAT Scientific Products, Guangzhou Jet Bio-Filtration, Zhejiang Gongdong Medical Technology, Zhejiang Biorear Biotechnology, Guangzhou MeCan Medical, Jiangsu Huida Medical Instruments, Vazyme, TPP Techno Plastic Products, Biosigma, Deltalab, Vitlab
Overview
Scope of the Report
The global Serological Pipettes market size is predicted to grow from US$ 231 million in 2025 to US$ 325 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.
The serum pipette is a precise liquid transfer consumable used in biology, medicine and clinical research. It is usually made of highly transparent polystyrene or high-quality borosilicate glass, with a double scale on the body and a filter core at the tip to prevent aerosol contamination. It is often used in conjunction with an electric pipette gun in a sterile operating environment for precise dispensing and transfer of milliliter volumes of liquid. The upstream supply chain of this product mainly consists of medical-grade high-transparency polystyrene (polymer resin) raw material suppliers, high-precision multi-chamber injection molding and extrusion mold manufacturers, high-density polyethylene filter core component suppliers, as well as medical-grade paper-plastic packaging material suppliers and ethylene oxide/gamma ray sterilization service providers. The midstream mainly consists of precision medical plastic injection molding and automated assembly enterprises with a thousand or hundred thousand level clean workshop, involving processes such as precise extrusion of the body, two-color printing, high-speed assembly of filter cores, and online visual defect detection. The downstream reaches the end laboratories through global research reagents and medical devices trading companies, e-commerce platforms and government procurement systems. Globally, the average single unit price of this niche product is $0.18. The global total sales volume in 2025 is 1.315 billion units, the global production capacity is 1.620 billion units, and the average industry net profit margin remains at 18.5%.
The future trend of this specialized product is to fully shift towards the use of bio-based or recyclable materials to meet the green laboratory environmental requirements, to modify the coating with superhydrophobic surface to reduce the residual of high-viscosity biological samples, and to design shorter tube bodies to conform to the ergonomics of ultra-clean workstations. The aim is to further improve the pipetting accuracy and reduce the repetitive strain on researchers. At the same time, the customized interface design that is compatible with high-throughput automated liquid handling workstations is gradually becoming widespread. The main driving factors for the growth of this market mainly stem from the vigorous development of global cell immunotherapy, antibody drug research and development, and vaccine industries, which have generated a huge rigid demand for sterile and heat-free, and nuclease-free cell culture consumables; in addition, the steady increase in the global volume of in vitro diagnostic tests in public health, as well as the continuous growth in government and private capital investment in biotechnology research and development, have also strongly driven the total purchase volume of consumable pipetting materials from the fundamental research level.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Serological Pipettes market?
What factors are driving Serological Pipettes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Serological Pipettes market opportunities vary by end market size?
How does Serological Pipettes break out by Capacity, by Application?
This report presents a comprehensive overview of the global Serological Pipettes market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Capacity
- Polystyrene
- Glass
Segment by Capacity
- 1mL
- 2mL
- 5mL
- 10mL
- 25mL
- 50mL
- 100mL
Segment by Sterility State
- Sterile Individually Wrapped
- Sterile Bulk Packed
- Non Sterile Bulk Packed
Segment by Application
- cademic Research Laboratories
- Pharmaceutical R&D Centers
- Clinical Testing Laboratories
- Blood Banking Facilities
- Biotechnology Production Facilities
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Serological Pipettes market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in cademic Research Laboratories, Pharmaceutical R&D Centers, Clinical Testing Laboratories evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Serological Pipettes Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Polystyrene
- 3.1.3 Glass
- 3.1.4 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 cademic Research Laboratories
- 4.1.3 Pharmaceutical R&D Centers
- 4.1.4 Clinical Testing Laboratories
- 4.1.5 Blood Banking Facilities
- 4.1.6 Biotechnology Production Facilities
- 4.1.7 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Corning
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Thermo Fisher Scientific
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Mettler Toledo
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Greiner Bio-One
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Eppendorf
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Sarstedt
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 DWK Life Sciences
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 CELLTREAT Scientific Products
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Guangzhou Jet Bio-Filtration
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Zhejiang Gongdong Medical Technology
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Zhejiang Biorear Biotechnology
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Guangzhou MeCan Medical
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Jiangsu Huida Medical Instruments
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Vazyme
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 TPP Techno Plastic Products
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
- 8.16 Biosigma
- 8.16.1 Company Overview
- 8.16.2 Key Products & Segments
- 8.16.3 Financial Performance (2023–2025)
- 8.16.4 Business Strategy
- 8.16.5 SWOT Analysis
- 8.16.6 Strategic Implications (2026–2032)
- 8.17 Deltalab
- 8.17.1 Company Overview
- 8.17.2 Key Products & Segments
- 8.17.3 Financial Performance (2023–2025)
- 8.17.4 Business Strategy
- 8.17.5 SWOT Analysis
- 8.17.6 Strategic Implications (2026–2032)
- 8.18 Vitlab
- 8.18.1 Company Overview
- 8.18.2 Key Products & Segments
- 8.18.3 Financial Performance (2023–2025)
- 8.18.4 Business Strategy
- 8.18.5 SWOT Analysis
- 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Serological Pipettes market?
How fast is the Serological Pipettes market expected to grow?
What does the Serological Pipettes market cover?
What are the main segments of the Serological Pipettes market by capacity?
Which applications drive demand in the Serological Pipettes market?
Who are the key players in the Serological Pipettes market?
Which regions and countries are covered for Serological Pipettes?
What is driving growth in the Serological Pipettes market?
Who should buy the Serological Pipettes market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Serological Pipettes Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices